A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC
Conditions
Colorectal Cancer (Diagnosis) · Colorectal Cancer Metastatic · Colorectal Cancer (CRC) · Immunotherapy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Liverpool Cancer Therapy Centre, Liverpool, New South Wales, Australia
Macquarie University Hospital (MUH), Macquarie Park, New South Wales, Australia
Scientia Clinical Research, Randwick, New South Wales, Australia
Greenslopes Private Hospital - Cyril Gilbert Cancer Centre, Greenslopes, Queensland, Australia
The Queen Elizabeth Hospital (TQEH), Woodville South, South Australia, Australia
Monash University - Faculty of Medicine, Nursing and Health Sciences, Clayton, Victoria, Australia
Austin Health - Cancer Clinical Trials Centre (CCTC), Heidelberg, Victoria, Australia
Linear Clinical Research, Nedlands, Western Australia, Australia
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City, Taiwan
E-Da Cancer Hospital, Kaohsiung City, Taiwan
Chang Gung Medical Foundation, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan
Taipei Medical University Shuang Ho Hospital, Ministry of Health and Welfare, New Taipei City, Taiwan
National Cheng Kung University Hospital, Tainan, Taiwan
National Taiwan University Hospital - Cancer Center, Taipei, Taiwan
Chang Gung Medical Foundation, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan